• Profile
Close

A phase II study of tumor ablation in patients with metastatic sarcoma stable on chemotherapy

The Oncologist Mar 08, 2018

Hirbe AC, et al. - Based on this prospective study it was suggested for the first time that ablation therapy for metastatic sarcoma can provide a significant progression-free interval off therapy in selected patients who are stable on chemotherapy.

Full text available Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay